• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Autoimmun . Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies

tetano

Editor, Senior Moderator
J Autoimmun


. 2021 Dec 13;126:102779.
doi: 10.1016/j.jaut.2021.102779. Online ahead of print.
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies


Saathvik R Kannan[SUP] 1 [/SUP], Austin N Spratt[SUP] 1 [/SUP], Kalicharan Sharma[SUP] 2 [/SUP], Hitendra S Chand[SUP] 3 [/SUP], Siddappa N Byrareddy[SUP] 4 [/SUP], Kamal Singh[SUP] 5 [/SUP]



Affiliations

Abstract

Severe Acute Respiratory Coronavirus (SARS-CoV-2) has been emerging in the form of different variants since its first emergence in early December 2019. A new Variant of Concern (VOC) named the Omicron variant (B.1.1.529) was reported recently. This variant has a large number of mutations in the S protein. To date, there exists a limited information on the Omicron variant. Here we present the analyses of mutation distribution, the evolutionary relationship of Omicron with previous variants, and probable structural impact of mutations on antibody binding. Our analyses show the presence of 46 high prevalence mutations specific to Omicron. Twenty-three of these are localized within the spike (S) protein and the rest localized to the other 3 structural proteins of the virus, the envelope (E), membrane (M), and nucleocapsid (N). Phylogenetic analysis showed that the Omicron is closely related to the Gamma (P.1) variant. The structural analyses showed that several mutations are localized to the region of the S protein that is the major target of antibodies, suggesting that the mutations in the Omicron variant may affect the binding affinities of antibodies to the S protein.

Keywords: B.1.1.529; COVID-19; Omicron variant; SARS-CoV-2; Variants.
 
Back
Top Bottom